Mega Lifesciences PCL (BKK:MEGA)

Mega Lifesciences PCL Income Statement

Financials in millions THB. Fiscal year is January - December.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	14,576	14,147	15,344	15,681	15,686	14,136
Other Revenue	52.04	47.34	41.09	34.41	40.64	36.67
Revenue	14,628	14,195	15,385	15,716	15,727	14,172
Revenue Growth (YoY)	-1.55%	-7.74%	-2.10%	-0.07%	10.97%	12.36%
Cost of Revenue	6,941	6,764	7,590	8,586	8,647	8,225
Gross Profit	7,687	7,431	7,796	7,130	7,080	5,947
Selling, General & Admin	4,542	4,481	4,385	4,191	4,359	3,769
Operating Expenses	4,542	4,481	4,385	4,191	4,359	3,769
Operating Income	3,145	2,950	3,411	2,939	2,722	2,178
Interest Expense	-60.88	-55.08	-38.49	-31.25	-28.73	-28.28
Interest & Investment Income	83.52	83.52	61.74	60.69	39.82	10.03
Earnings From Equity Investments	-7.63	-0.33	0.15	0.07	0.18	-1.51
Currency Exchange Gain (Loss)	-509	-573.9	-1,082	-706.57	-138.16	118.52
EBT Excluding Unusual Items	2,651	2,404	2,352	2,262	2,595	2,277
Pretax Income	2,651	2,404	2,352	2,262	2,595	2,277
Income Tax Expense	584.41	492.21	339.63	269.06	354.63	336.02
Earnings From Continuing Operations	2,067	1,912	2,013	1,993	2,240	1,941
Minority Interest in Earnings	0.02	0.02	-0.07	0.05	1.49	5.97
Net Income	2,067	1,912	2,012	1,993	2,242	1,947
Net Income to Common	2,067	1,912	2,012	1,993	2,242	1,947
Net Income Growth	4.13%	-4.99%	0.99%	-11.10%	15.14%	39.79%
Shares Outstanding (Basic)	875	872	872	872	872	872
Shares Outstanding (Diluted)	875	872	872	872	872	872
Shares Change (YoY)	0.32%	-	-	-	-	-
EPS (Basic)	2.36	2.19	2.31	2.29	2.57	2.23
EPS (Diluted)	2.36	2.19	2.31	2.29	2.57	2.23
EPS Growth	3.80%	-4.99%	0.99%	-11.10%	15.14%	39.79%
Free Cash Flow	-	2,107	2,154	1,652	1,692	2,575
Free Cash Flow Per Share	-	2.42	2.47	1.90	1.94	2.95
Dividend Per Share	1.600	1.600	1.600	1.600	1.600	1.380
Dividend Growth	-	-	-	-	15.94%	53.33%
Gross Margin	52.55%	52.35%	50.67%	45.37%	45.02%	41.97%
Operating Margin	21.50%	20.78%	22.17%	18.70%	17.30%	15.37%
Profit Margin	14.13%	13.47%	13.08%	12.68%	14.25%	13.74%
Free Cash Flow Margin	-	14.84%	14.00%	10.51%	10.76%	18.17%
EBITDA	3,350	3,154	3,614	3,146	2,917	2,378
EBITDA Margin	22.90%	22.22%	23.49%	20.02%	18.55%	16.78%
D&A For EBITDA	204.43	203.96	202.84	207.49	195.24	200.2
EBIT	3,145	2,950	3,411	2,939	2,722	2,178
EBIT Margin	21.50%	20.78%	22.17%	18.70%	17.30%	15.37%
Effective Tax Rate	22.04%	20.47%	14.44%	11.90%	13.67%	14.76%
Revenue as Reported	14,712	14,278	15,447	15,776	15,767	14,301
Advertising Expenses	-	1,255	1,232	1,323	1,266	1,052

Source: S&P Global Market Intelligence. Standard template. Financial Sources.